Skip to content
Agendia logo

Agendia Alternatives & Competitors

12 companies similar to Agendia — MammaPrint® + BluePrint® provides you with actionable insights throughout your p...

Companies similar to Agendia

Guardant Health logo — alternative to Agendia

Guardant Health

Conquering Cancer With Data

Castle Biosciences, Inc. logo — alternative to Agendia

Castle Biosciences, Inc.

Improving health through innovative tests that guide patient care

Veracyte, Inc. logo — alternative to Agendia

Veracyte, Inc.

Cancer Genomic Testing & Molecular Diagnostics | Veracyte Inc.

GeneCast Biotechnology Co., Ltd. logo — alternative to Agendia

Rival Readout

Competing with Agendia? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
Diatech Pharmacogenetics logo — alternative to Agendia

Diatech Pharmacogenetics

Leader in the development, production and sales of pharmacogenetics tests for cancer preci...

Strand Life Sciences logo — alternative to Agendia

Strand Life Sciences

Personalized Genomics For A Healthier Future

Empire Genomics logo — alternative to Agendia

Empire Genomics

The First Choice For Fluorescence In Situ Hybridization

Personalis, Inc. logo — alternative to Agendia

Personalis, Inc.

Ultrasensitive ctDNA testing

Predicine logo — alternative to Agendia

Predicine

Advancing precision medicine through next-generation liquid biopsy oncology platform

LCM Genect logo — alternative to Agendia

LCM Genect

Enable precision medicine

OncoDNA logo — alternative to Agendia

OncoDNA

Genomic and theranostic company specializing in precision medicine for the treatment of ca...

ASC Oncology GmbH logo — alternative to Agendia

ASC Oncology GmbH

RETHINK ONCOLOGY

About Agendia

Agendia is a precision oncology company headquartered in Irvine, California, committed to providing patients with early stage breast cancer and their physicians the information they need to make the best treatment decisions. The company currently offers two commercially-available genomic profiling tests: MammaPrint®, a...

Services

Genomic Testing Platforms, Molecular Subtyping, Data Analysis for Treatment Planning, Clinical Trial Support

Target Customers

Healthcare Providers, Medical Institutions, Breast Cancer Patients, Patient Advocacy Partners, Research Institutions

Business keywords

Precision Oncology, Genomic Profiling, Molecular Subtyping, Cancer Recurrence Assay, Clinical Evidence, Real World Evidence, Treatment Guidelines, Next-Generation Diagnostics, Personalized Treatment, Breast Cancer, Genomic Testing, Medical Research, Digital Treatment Tools, Clinical Decision Support, Biopsy Analysis

Frequently Asked Questions

Companies similar to Agendia include Guardant Health, Castle Biosciences, Inc., Veracyte, Inc., GeneCast Biotechnology Co., Ltd., Diatech Pharmacogenetics. They work in Biotechnology and Health Care and share Agendia's focus on clinical decision support, personalized treatment and genomic profiling.
Bounce Watch lists 12 companies that share Agendia's industries and are closest to it in business tags, services, target customers, business model and size.
Agendia is a precision oncology company headquartered in Irvine, California, committed to providing patients with early stage breast cancer and their physicians the information they need to make the best treatment decisions. The company currently offers two commercially-available genomic profiling tests: MammaPrint®, a...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Agendia: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Agendia on 7 Feb 2025. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout